From: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples
 | Detection of SARS-CoV-2 viral peptides by SISCAPA approach |  | |
---|---|---|---|
Positive | Negative | Â | |
SARS-CoV-2 positive nasopharyngeal swab samples (n = 41) | 38 | 3 | Sensitivity-92.68% |
SARS-CoV-2 negative nasopharyngeal swab samples (n = 30) | 30 | 0 | Specificity- ~ 100% |